A BIORAMICS COMPANY
We Improve
Cellular Dispersion
The same cells can produce materially different outcomes depending on how they dispense after delivery.
Agerea is an innovative technology controlled by SCRM Bio, LLC designed to reduce post delivery aggregation and support broader spatial distribution of viable cells within tissue environments.
Same Cells. Different Outcomes.
Cells delivered without Agerea cluster near the injection site. With Agerea, cells are more uniformly distributed throughout the tissue.
Uniform distribution across tissue
Reduced aggregation
Increased viable cell presence
Enhanced therapeutic outcomes
Cells cluster at injection site
Limited dispersion
Reduced viability
Reduced therapeutic potential
Agerea Particle Surface Transformation
Before reaction, Agerea precursor particles have irregular shapes with smooth sides and edges.
After reaction, Agerea particles have a roughened surface texture that helps adhere to cells which are sticky.
Why It Matters
Cell therapies often face a delivery problem, not just a cell quantity problem.
Agerea is intended to address a critical post delivery challenge: cells can aggregate at the injection site rather than disperse through the target tissue.
By improving dispersion behavior, Agerea may help increase the practical effectiveness of cell based therapies and improve consistency across research and clinical development workflows.
Improved
Dispersion
Reduced
Aggregation
Greater Viable
Cell Presence
